Medpace Voice

Medpace oncology experts examine the clinical and operational concepts driving the next phase of oncology development presented at 2025 ASCO.

Medpace is proud to announce the expansion of our logistics hub in Leuven, Belgium – a major milestone in our...

As cardiovascular clinical trials evolve, imaging biomarkers have become essential tools for enriching patient populations, evaluating therapeutic response and accelerating...

Clinical and Regulatory Considerations for Advancing Urinary Tract Infection (UTI) Drug Development in Women

Explore insights from Medpace medical and operational experts as they identify key themes from ESCMID Global 2025.

In this webinar, experts provide a comprehensive overview of the current state of the clinical development landscape for rheumatology, along with strategies to drive success…

Medpace is proud to announce the expansion of our microbiology capabilities at our state-of-the-art central laboratories in Cincinnati, Ohio, and...

As biopharmaceutical companies seek to optimize clinical trial design, accelerate regulatory approvals, and improve patient outcomes, insights from JSMO 2025 provide a critical foundation for…

In January 2025, the FDA released updated guidance titled “Obesity and Overweight: Developing Drugs and Biological Products for Weight Reduction.” The FDA...

Every cancer journey is unique—shaped by the individual, the disease, and the evolving landscape of treatment.